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Summary Understanding the mechanisms of molecular self-assembly processes in natural
materials is an important step to developing new functional materials with useful properties.
Recently, various self-assembled materials have gained attention because of their interest-
ing properties in nanoscale. Nanostructures composed of peptides are especially of interestAmphiphiles;
Supramolecular
chemistry
in materials development because of their many advantageous properties such as biodegrad-
ability, biocompatibility and customizable bioactivity. Self-assembled peptidic nanostructures
have been studied by many research groups and found use as three-dimensional cell scaffolds
for bone regeneration, dental implants, neural tissue engineering, biosensors for detection of
viruses and other pathogens, antibacterial agents and in drug, protein and gene delivery.
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ife was made possible by the assembly of monomers such
s nucleic acids, fatty acids, amino acids, which came
ogether to form larger molecules, namely proteins, car-
ohydrates and lipids. By understanding the mechanisms
f self-assembly processes in living organisms, scientists
ealized that self-assembling structures could provide vast
pportunities for the design of new materials for both bio-
ogical and non-biological applications, in ﬁelds such as
egenerative medicine [1—4], electronics [5—8] and optics
9]. Molecular self-assembly is a technique in materials
esign, involving non-covalent interactions such as hydrogen
onding, hydrophobic, electrostatic, metal—ligand, —
nd van der Waals interactions. These interactions are
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ighly dynamic and often delicate due to their relatively
eak nature, varying from less than 5 kJmol−1 for van der
aals interactions to up to 120 kJmol−1 for hydrogen bond-
ng, compared to covalent bonds which can have energies
p to 400 kJmol−1 [10]. However, a sufﬁcient number of
hese weak interactions can yield a stable assembly. Various
elf-assembled supramolecular nanostructures have been
repared using these non-covalent interactions [11—14] and
any new self-assembling materials can be designed to
rganize into ordered complex structures by understanding
he mechanisms of these assembly processes.
upramolecular nanostructure formation
nspired by naturenderstanding interactions in assembly mechanisms of bio-
ogical molecules has become a crucial factor in designing
anoscale materials. Among various examples of self-
ssembling molecules found in the nature, proteins are of
articular interest in terms of supramolecular organization.
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Proteins are formed by tertiary structures of peptide sec-
ondary structures. The information needed for secondary
and tertiary structures are encoded in the amino acids,
which are the smallest protein building blocks that carry
the information needed to create higher levels of orga-
nization. Amino acids can contain chirality, electrostatic
dipoles, ionizable groups, hydrogen-bond donors and accep-
tors, hydrophobic domains and metal binding ligands [15]. A
considerable number of the interactions in proteins consist
of either -helix or -sheet secondary structural compo-
nents of peptides [16].
One of the most abundant protein-folding motifs is the
‘coiled-coil’ [17], in which -helices with a seven-residue
repeat sequence are coiled intertwiningly. One year after
the discovery of the structure of -helix by Pauling et al.
[18], Crick proposed that the structure of -keratin is based
on coiled coils [19]. Most coiled-coils adopt a left-handed
structure although it is possible to ﬁnd some right-handed
coiled coils naturally or artiﬁcially [20].
Leucine zippers, named by Landschulz et al. [21], are
a special type of coiled-coil structural motif involved in
the dimerization of a number of transcription factors, the
best characterized and most versatile coiled-coil structure
being the leucine zipper of the yeast transcriptional factor
GCN4 [22]. The interactions stabilizing the leucine zippers
are hydrophobic interactions between nonpolar side chains
and the intra- and interhelical electrostatic interactions
between charged amino acids [23].
Amyloid plaques contain a different type of structure
formed by very stable peptide and protein complexes
[24,25]. Amyloid ﬁbers implicated in Alzheimer’s disease are
composed of well-ordered -sheet structures and are sensi-
tive to the amino acid sequence forming the peptide. The
-sheet structures found in the amyloid proteins provide a
strong and stable aggregation. Inspired from the mechanical
stability of the amyloid systems, new functional nanoscale
materials can be designed based on the -sheet secondary
structures of the peptides [8].
Interest in self-assembly of peptides and proteins has
been motivated not only by a concern to understand
the mechanisms of pathological aggregation but also to
understand the functions and mechanisms of higher order
assembly of proteins such as collagen. Natural collagen has
been found useful in enhancing cell adhesion [26], tissue
regeneration [27—29], and drug delivery [30,31]; therefore,
scaffolds and biomaterials mimicking the natural collagen
and enhancing its biological functions have been generated
[32—36].
Tobacco mosaic virus (TMV) is another form of
supramolecular nanostructure, assembled from a single
strand of mRNA and many copies of identical coat proteins
helically organized into a rod-like shape [37]. The RNA is
inserted between the protein turns with three nucleotide
residues per protein subunit. Each protein subunit is situated
at a radial distance of 4 nm from the central axis, where the
outer diameter of the formed nanotube is 18 nm. The protein
arrangement forces the RNA backbone into a moderately
extended single-strand conﬁguration which forms the cen-
tral axis of the virus particle within a cylindrical hole. TMV
capsule has multiple applications as a scaffold to fabricate
materials with nanoscale order [38—40] due to its well-
deﬁned structure, stability and easy mass production (Fig. 1)

o
t
igure 1 The assembly of the tobacco mosaic virus. Repro-
uced with permission from Ref. [41].
41,42]. Although use of the TMV as templates for selec-
ive deposition has been achieved, the covalent attachment
f small molecules to the capsid has been more difﬁcult to
chieve. That the future applications will depend critically
n functionalization, Schlick et al. developed new synthetic
ethods which enable functionalizing capsids without dis-
upting their assembly [43]. As a result of these studies, the
sefulness of TMV for construction of nanoscale materials
as been increased dramatically. The utilization of the mod-
ﬁed capsids as carriers for drug and gene delivery is under
nvestigation.
eptide-based supramolecular nanostructures
ynthetic methodologies provide routes for creating peptide
equences that are useful in the formation of supramolec-
lar nanostructures [44,45]. These peptides include amino
cid residues carrying speciﬁc information on their side
hains such as hydrophilicity, hydrophobicity and chirality.
ydrophobic and hydrophilic residues affect peptide assem-
lies through the formation of -sheet and -helix secondary
tructures [16].
-Helical based nanostructures-Helices are the most common form of regular sec-
ndary structure of proteins. The -helical assemblies
end to be more reversible than the -sheet units. Several
-helical based nanostructures have been designed for
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Figure 2 (a) TEM image of a self-assembling branched pepti
ssembled ﬁber peptide building blocks of linear and branched
he construction of systems with engineering biological
ctivity.
Coiled-coil peptides are an example of supramolecular
tructures that can be used to present functional epitopes
n high density [46]. Coiled-coil structural motifs produced
y the helical peptides form self-assembled ﬁlaments, as
hown in Fig. 2.
Coiled-coils are widely used in folding motifs consisting
f 2—5 helices that are wrapped around each other in a
uperhelical fashion. A heptad periodicity in the amino acid
a
a
r
h
i
igure 3 The amino acid organization in coiled-coil helical peptidb) SEM image of a self-assembling branched peptide. (c) Self-
s. Reproduced with permission from Ref. [46].
equence, —a—b—c—d—e—f—g—, is used to form the coiled-
oil structures [47] (Fig. 3). In this case, hydrophobic amino
cids are inserted in the ‘a’ and ‘d’ positions. The amino
cids at positions ‘a’ and ‘d’ and ‘e’ and ‘g’ determine the
ggregation number of the coiled-coil structure and the rel-
tive orientation of the constituent helices, respectively. In
ddition, electrostatic interactions are also used to develop
eversible peptide assemblies. Coiled-coil nanostructures
ave been used to form hydrogels with potential uses as
n situ depots for protein delivery [48].
e formation. Reproduced with permission from Ref. [47].
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In the case where the interacting surface between the
helices contains leucine, the structure is called a ‘leucine
zipper’. Various research groups designed leucine zippers for
nanostructures with different properties [49,50]. O’Shea et
al. were the ﬁrst to propose a design in which one strand
with acidic residues and the other with basic residues yields
a parallel heterodimer, named as ‘Peptide Velcro’ [49]. An
asparagine residue, which is uncharged, is buried inside and
this contributes to the speciﬁcity of the helix orientation and
oligomerization state. Simple sequences can be designed to
have a very high preference to pair with each other, so the
‘Peptide Velcro’s could be utilized to bring two molecules
together, either in vitro for sensing applications or in cell.
Ryadnov et al. designed a system, called ‘belt-and-
braces’, where two peptides (braces) are bound together
by a third peptide (belt) of opposite charge [50]. A six-
heptad design was adopted for the belt and braces, with
the braces having three heptads each. The peptides were
designed such that braces were directed to opposite ends
of the belt, so that the braces could be functionalized at
their termini of interest. Braces coupled with colloidal gold
nanoparticles required the addition of the belt in order to
form nanoscale networks, claimed to be the ﬁrst example
of peptide-mediated nanoparticle assembly.
-Sheets based nanostructures
The -sheet is the second common form of regular sec-
ondary structure in proteins consisting of -strands, which
are connected laterally by three or more hydrogen bonds,
forming a twisted, pleated sheet. A -sheet unit has exten-
sive hydrogen bonding between the carbonyl oxygen of
an amino acid in one strand and the nitrogen of a sec-
ond amino acid in another strand. The hydrogen bonding,
along with the contribution of hydrophobic effects, sta-
bilizes the -sheets. -Sheets can be either parallel, two
-sheet units aligned in the same direction from one ter-
minus to the other, or antiparallel, the units aligned in the
opposite direction. Recent research has focused on the role
of -sheet-rich ﬁbrillar structures in neurodegenerative dis-
eases such as Alzheimer’s, Parkinson’s, Creutzfeldt-Jakob’s
diseases in humans, and bovine spongiform encelophalopa-
thy and scrapie in animals [51—57]. The ability to design
-sheet nanostructures to self-assemble into amyloid-like
g
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d
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Figure 4 Tripeptide-based self-assembling amphiphilic m461
brils, where the fundamental unit of amyloid ﬁbrils is found
o be a steric zipper formed by two tightly interdigitated
-sheets [58], has helped researchers to understand the
olding and pathogenesis mechanisms better, and enabled
he generation of new biomaterials with interesting proper-
ies [59—64].
Based on the structure of a natural -barrel protein, the
-hemolysin pore of S. aureus [65] inspired the construc-
ion of synthetic self-assembling molecules to form -barrels
y using -sheets. Rigid-rod -barrels based on assembly of
cta(p-phenylene)s were synthesized with -peptide side
hains interdigitated with side chains of adjacent staves
66] (Fig. 4). Turning the -barrels inside out enables the
arrels to form synthetic pores in membrane bilayers. Syn-
hetic, multifunctional pores can be used as speciﬁc and
elective enzyme sensors [67,68]. In addition to structures
hat mimic -barrels, another approach to forming helical
ore structures has been through the use of amphiphilic
endritic dipeptides [69]. The porous structure of the assem-
led pores enabled proton translocation at a rate similar to
ramicidin channels. Barrel proteins and -helices formed
y gramicidin A are mainly formed by the -sheet hydro-
en bonding structures [70]. The -sheet hydrogen bonding
ith a degree of curvature results in formation of aggregated
anostructures [71,72] (Fig. 5).
Another example of -sheet containing nanostructures
re self-assembling macrocycles containing an even num-
er of alternating D- and L-amino acids [73—75]. Strong
ydrogen bonding between the individual macrocycles
ields high-aspect-ratio nanostructures containing two-
imensional -sheets. The inner diameter of the peptide
anotubes is controlled by the number of amino acids in the
acrocycle [76]. Structures based upon macrocycles have
een used as antibacterial agents, which act by solubilizing
r disrupting the bacterial membrane [75,77] (Fig. 6).
mphiphilic peptides based nanostructures
mphiphilic peptides consist of a hydrophilic peptide head-
roup and a hydrophobic alkyl tail where the headgroup
ncorporates a bioactive sequence and the tail has a role
o align the headgroup, promote self-assembly, and induce
esirable secondary, super-secondary and tertiary confor-
ations [78—82]. The self-assembly leading to different
olecule. Reproduced with permission from Ref. [66].
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Figure 5 Nanotubes derived by -sheet forming mole
structures is related to standard free energy change dur-
ing aggregation. The concept of opposing forces of Tanford,
hydrophobic attractions at the water—hydrocarbon inter-
faces and the hydrophilic, ionic or steric repulsion between
the headgroups, was the ﬁrst explanation for growth and
shape of surfactant aggregates [83]. Although Tanford forces
had originally been devised for lipid molecules, it can be
applied to amphiphilic molecules, including amphiphilic
peptides. However, Tanford forces may not be sufﬁcient
to explain all amphiphilic peptide aggregations [84]. The
molecular packing parameter (p), determining the ﬁnal
shape, is deﬁned as Vo/Aolc, where Vo is the volume occupied
by tail, lc is the critical tail length and Ao is the optimal area
per headgroup. For p < 1/3, spherical micelles are favored;
for p between 1/3 and 1/2, cylindrical micelles are favored;
for p between 1/2 and 1, ﬂexible bilayers and vesicles are
favored [85]. For many amphiphilic peptides, the packing
parameter is between 1/2 and 1; but instead of bilayers,
nearly all form cylindrical structures. According to Tsonchev
et al., the mechanism of self-assembly of amphiphilic pep-
tides is not only composed of hydrophobic interactions, but
also contains electrostatic interactions [84]. The formation
Figure 6 A bacterial membrane model: the annihilation
mechanism of macrocycles as antibacterial agents. Reproduced
with permission from Ref. [77].
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f a -sheet due to hydrogen bonding between the pep-
ide parts of the molecules plays also an important role in
he self-assembly. Unlike spherical micelles, the hydrophilic
eadgroups of cylindrical micelles are attractive. The strong
irectional electrostatic interactions of headgroups com-
eted with attractive hydrophobic interactions of tails under
he conditions of a pH between 2 and 4, where in the case
f amphiphilic peptides, the winner was the electrostatics.
he Monte Carlo simulations showed that the ﬁnal structure
as spherical in the absence of electrostatic interactions.
A more recent study on the self-assembly mechanism of
eptide amphiphiles by Velichko et al. revealed that the
ydrogen bonding is the main interaction contributing to
he ﬁnal shape [86]. They modelled the headgroups as elec-
roneutral, meaning that the acidic peptide amphiphiles
orm ﬁbers under acidic conditions and basic peptide
mphiphiles under basic conditions in order not to calculate
he effects of electrostatics in the self-assembly process.
herefore, the Monte Carlo-stochastic dynamics simulations
an be done in a reasonable time while capturing various
spects of the process. According to their coarse-grained
odel, transitions from random molecules in solution to
ifferent micellar structures are based on the interaction
etween hydrophobic interactions and hydrogen bonding.
Amphiphilic peptides are developed to form nanos-
ructures for various applications in many areas of
anotechnology. Simple structures inspired from the -
myloid core motif, dipeptides formed by phenylalanines,
ave been shown to form nanotubes in aqueous solutions
87]. Amyloid-forming peptides with metal binding capac-
ty have found applications as templates for the fabrication
f low resistance, conducting nanowires [8,88]. Cysteine
esidues acted as nucleation sites for deposition of metal
n the protein, also serine amino acids deposited plat-
num and gold nanoparticles. Gazit and co-workers also
ompared the antiamyloidogenic action mechanism of phe-
olsulfonphthalein to phenolphthalein [89]. Understanding
he amyloid ﬁbril assembly mechanism better might help
uring the design process of antiamyloidogenic inhibitors;
s amyloidogenesis is related to many neurodegenerative
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diseases, designing molecules with inhibitor potency is very
important. Although the primary structure of these two
molecules is very similar, their 3D structures differ from
each other, resulting in different inhibitory potentials. Phe-
nolsulfonphthalein has been shown to be a very inﬂuential
inhibitor for amyloid ﬁbril formation whereas phenolph-
thalein did not show any signiﬁcant activity. Other molecules
designed by Gazit et al. with antiamyloidogenic activity
include indole-based molecules [90], peptides modiﬁed with
-aminoisobutyric acid sequence as  breaker [91], and
polyphenols [92].
Ulijn and co-workers designed amphiphilic peptides with
a 9-ﬂuorenylmethoxycarbonyl (Fmoc) group and a dipheny-
lalanine dipeptide [93]. The Fmoc dipeptides, composed of
combinations of 4 different amino acids, namely glycine,
alanine, leucine and phenylalanine, have been shown to
form hydrogels with different structural and physical proper-
ties depending on the amino acid composition of the peptide
building blocks. By incorporating a basic amino acid (lysine)
into the mixture, hydrogels stable at physiological pH could
be formed. These hydrogels are composed of nanostruc-
tures similar to the ﬁbrillar components of extracellular
matrix (ECM) as mechanical support for cells. The hydrogels
were manufactured into solid biocompatible molds for drug
encapsulation and controlled drug release; also, they have
been shown to be suitable as scaffolds for cell growth in two
and three dimensions. In a later study, Fmoc protected Arg-
Gly-Asp (RGD) peptide building blocks have been shown to
form hydrogels and to promote adhesion of human dermal
ﬁbroblasts through speciﬁc RGD—integrin binding, with sub-
sequent cell spreading and proliferation [94]. One important
aim in the design of synthetic tissue scaffolds is to mimic the
structure and function of the extracellular matrix providing
a cellular microenvironment with characteristics similar to
those encountered in vivo. The ECM organizes cells into tis-
sue, affects overall cellular architecture, provides pathways
for migratory cells, participates in signal transduction path-
ways and strengthen tissues. Therefore, while designing a
scaffold, biodegradability and mechanical properties must
be taken into consideration besides addition of growth fac-
tors and functionalization of the scaffold with short amino
acid sequences that mimic the adhesion domains of ECM. In
some cases, scaffolds which degrade fast and release the
bioactive molecules are desirable, in other cases one might
wish to have a slowly degrading scaffold which maintains
its integrity and structure for a longer time. If the scaffold
is going to be used for a load-bearing tissue, especially dur-
ing the early growth phase, sufﬁcient temporary mechanical
integrity for the scaffold is required to withstand the in vivo
stress and loading.
Bolaamphiphiles are another class of amphiphilic
molecules that have hydrophilic groups at both ends of
a hydrocarbon chain [95]. Introduction of a second head-
group to single-headed amphiphiles has been shown to
induce a higher solubility in water [96]. Synthetic unsym-
metrical bolaamphiphiles developed by Claussen et al.
contain (L-glutamyl)3-glycine at one terminus and either
tetraethylene glycol or aspartic acid at the other [97].
The peptidic segment of the bolaamphiphile undergoes -
sheet hydrogen bonding to form various supramolecular
nanostructures; bolaamphiphiles that give rise to structures
such as ﬁbers, rods, tubes, ribbons, and spheres have been
t
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eveloped [97—102]. Bolaamphiphile nanotubes have been
mplemented as viral assays [103] even when the pathogens
re label-free [104], and for protein sensing [105], among
ther interesting applications.
Zhang et al. revealed that alternating hydrophilic and
ydrophobic amino acids of a region of the Z-DNA binding
uotin protein [106] could be used to form nanoﬁbers, where
he alternating residues induce a stable -sheet structure.
llis-Behnke et al. used a similar class of peptide nanoﬁbers
o regenerate axons to reverse vision loss in rodents to cor-
ect central nervous system problems [107]. Self-assembling
eptide nanoﬁber scaffolds were modiﬁed at the amino ter-
inal with sequences derived from collagen IV or laminin I
108]. Addition of these sequences has enhanced the adhe-
ion and spreading rate of human aortic endothelial cells.
n another study, the peptide nanoﬁbers were combined
ith epithelial growth factor, mimicking the structure and
orosity of ECM to improve the rate of wound healing on
uman skin equivalent tissue model [109]. Such modiﬁed
caffolds have been shown to be useful as cell cultures for
ouse neural stem cells [110] and pre-osteoblast cells [111].
he nanoﬁbers developed by Zhang et al. can be applied
y injecting into myocardium, creating an intramyocardial
icroenvironment for mouse endothelial cells that promotes
ascular cell recruitment [112].
Peptide amphiphile molecules forming different types of
anoﬁbers were developed by Hartgerink et al. [113]. The
upramolecular sheets have a tendency to hide hydrophobic
egments from water and collapse into cylindrical nanos-
ructures [113] (Fig. 7). These peptide amphiphile molecules
ere designed with biologically active peptides respon-
ible for cell adhesion. Cysteine residues were used to
tabilize the aggregate by means of cross-linking. The
hosphorylated serine residue was used to interact with
alcium ions for mineralization of hydroxyapatite. The
et charge of the system keeps molecules dissolved in
ater as a result of coulombic repulsion. Neutralization
f the charged groups triggers the self-assembly process
hat includes the hydrogen bond formation among the pep-
ide sequences. As the nanoﬁbers grow, they bundle and
orm a network in water, which results in self-supporting
el formation. An arginine-glycine-aspartic acid (RGD) pep-
ide sequence, playing a role in integrin-mediated cell
dhesion, was integrated into the structure. Linear and
yclic RGDS sequences were also presented on N-terminal
f peptide amphiphile nanoﬁbers [114], where not only
GDS but also other bioactive signals were used such
s biotin [115]. In case the nanoﬁbers assemble from
ranched peptide amphiphiles, the branched covalent archi-
ecture leads to greater accessibility of binding sites. This
lass of self-assembled nanostructures were developed as
ioactive scaffolds for enhanced epitope recognition to
mprove cell adhesion event [114,116], for tissue engi-
eering applications [117,118] and magnetic resonance
maging in a bound form to contrast agents [119]. Sargeant
t al. fabricated hybrid bone implants, where peptide
mphiphile nanoﬁbers were self-assembled within porous
itanium [120]. Their results demonstrated cell encapsula-
ion in the implants, vascularization around the implant,
nd mineralization of calcium phosphate with a Ca:P ratio
imilar to that of hydroxyapatite, a calcium phosphate
ineral. Their strategy could be tailored to induce new
464 S. Toksöz, M.O. Guler
Figure 7 Peptide amphiphile chemical structure demonstrating, alkyl tail (1), consecutive cysteine residues (2), ﬂexible linker
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tegion of three glycine residues (3), a single phosphorylated se
ermission from Ref. [113].
one formation and improve thereby ﬁxation, osteointe-
ration and long-term stability of implants. There are
arious applications of self-assembling nanoﬁbers as scaf-
olds for neural progenitor cells [2], dental stem cells [121],
or cell entrapment [122], and to stimulate angiogenesis
123].
Aulisa et al. designed peptide amphiphile molecules
argeted against proliferation of cancer cells [124]. The con-
entration of peptide amphiphiles was chosen low in order
o form spherical micelles. The concentration at which pep-
ide amphiphiles are used determines the ﬁnal structure.
bove its critical micelle concentration, a single tail peptide
mphiphile molecule at high concentration assembles into
anoﬁbers, whereas low concentrations result in micelle for-
ation. The design mimics a hexapeptide motif of HOX gene,
subgroup of homeobox genes found in clusters on the genes
f vertebrates and playing a role in directing embryonic
evelopment, and inhibits the HOX/PBX complex formation,
hereby preventing DNA transcription.
Schneider et al. designed a 20 amino acid long pep-
ide, MAX1, which consists of two -strands with alternating
aline and lysine residues connected via a type II’  turn.
AX1 ﬁrst folds into -hairpin structure under basic con-
itions and then self-assembles into hydrogel [125,126]
Fig. 8). The -hairpin hydrogel promotes the growth and
roliferation of ﬁbroblast cells [127] and has been shown to
e effective against prevalent hospital bacteria [128].
d
F
w
a
aresidue (4) and cell adhesion ligand RGD (5). Reproduced with
Hydrogels prepared from MAX1 and MAX8 were useful for
ncapsulating and releasing model biomacromolecules in a
ontrollable fashion [129]. MAX1 and MAX8 are same except
point substitution on the hydrophilic face of the hairpin
here a lysine in MAX1 is substituted by a glutamic acid in
AX8. This substitution changed the overall charge state of
he peptide at physiological pH. Also, the glutamic acid of
AX8 repelled the circumjacent negatively charged groups.
oth mesh size and electrostatics between the gel network
nd macromolecule have been shown to inﬂuence macro-
olecular mobility within the gel network. By changing the
eptide weight percent and the amino acid sequence, it
s possible to control the mesh size and consequently the
robe diffusion and release rate of macromolecules from
he -hairpin peptide hydrogels.
Amphiphilic peptides have also found applications in
rug delivery [130,131]. ,-Dehydrophenylalanine residues
ontaining amphiphilic dipeptides, H-Glu-Phe-OH and H-
ys-Phe-OH, self-assemble into nanovesicles and can
ontain small molecules such as vitamins, peptides and
mall proteins. The advantages of using nanovesicles are
hat they are resistant against proteases, are stable and
o not show cytotoxicity in cell culture conditions [130].
or drug delivery, -sheet nanoribbons have been used as
ell. A cyclic Arg-Gly-Asp (RGD) peptide segment has been
dded to a -sheet forming peptide segment, which self-
ssembled into a nanoribbon structure [132] (Fig. 9). This
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ﬁFigure 8 Model for the folding and self-assembly
nanoribbon has been shown to encapsulate hydrophobic
molecules and be internalized into cells through integrin
receptors.
Using -sheet peptide-based nanoribbons as building
blocks, ﬁlament-shaped artiﬁcial viruses for gene and drug
delivery have been designed [133]. The hydrophobic and
electrostatic interactions produced by the tryptophan-
lysine-tryptophan-aspartic acid repeats in the -sheet
peptide segment promote the formation of nanoribbons by
self-assembly of -sheet peptides. It has been shown that
for gene delivery, siRNA, a double-stranded RNA that is
21—23 nucleotides in length and induces RNA interference,
could be encapsulated within the carbohydrate surfaces
without disordering the discrete nanoribbon structure [133].
h
o
m
L
h
Figure 9 Self-assembly of the nanoribbon by a cyclic RGD segme
forming peptide segment (Phe-Lys-Phe-Glu-Phe-Lys-Phe-Glu: FKE). RAX1. Reproduced with permission from Ref. [126].
nother use of nanoribbons, containing a carbohydrate
nd a polyethylene glycol spacer, has been in the area of
ontrolling bacterial motility and agglutination [134]. It has
een proven that the spacer length must have a sufﬁcient
ength in order to stabilize the nanoribbon structure,
hich increased the efﬁciency of the nanoribbon to inhibit
otility and agglutination of bacteria.
Tirrell and Fields developed amphiphilic peptides modi-
ed at the N-terminal with monoalkyl [78] or dialkyl [135]
ydrocarbon chains, demonstrating the effect of lipid tails
n stabilization of desired molecular structures during for-
ation of triple helices, a structure found in collagen.
ipidation of peptides also induced the formation of -
elical structures [79,81]. These nanostructures have been
nt, a ﬂexible linker segment (Ser Gly-Ser-Gly) and a -sheet
eproduced with permission from Ref. [132].
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hown to promote adhesion and spreading of melanoma cells
81]. Cavalli et al. formed an amphiphilic lipopeptide, to
orm antiparallel -sheets, by combining the water-soluble
Leu-Glu)4 octapeptide with a phospholipid moiety [136]
Fig. 10). The self-organizing -sheet template was devel-
ped to mineralize calcium carbonate.
ollagen-like peptides
ollagen, providing the structural and organizational frame-
ork for cartilage, bone, tendon, blood vessels, skin, and
ascia, is the essential structural component of the con-
ective tissue. Collagen consists of three left-handed alpha
hains that are supercoiled around a common axis to form a
ight-handed superhelix, called ‘‘triple helix’’. Every third
esidue of the helix points inwards, sterically where only
lycine ﬁts. A frequent motif found in the triple helix is
lycine-Y-X. X and Y can be the imino acids proline or
ydroxyproline, but hydroxyproline contributes more stabil-
ty at the Y position due to the stereoelectronic promotion
f the more favorable exo ring pucker and forming hydro-
en bonds with water molecules surrounding the triple helix
137,138]. In collagen diseases, a change of a single glycine
nto another amino acid with a larger side chain is not
ncommon [139,140].
The triple helix constitutes a rod-like structure impor-
ant for ﬁbril formation and structural integrity; it also
nteracts with a wide range of molecules important in
xtracellular matrix organization and function. Natural col-
agen has been used for various biomedical applications
27,31,141—143,145]; however, there are risks [146—149]
f using natural products such as contamination with
rions, viruses or some other molecules and allergic reac-
ions. As a result, collagen-like model peptides that would
orm triple helices and self-assemble into supramolecu-
ar ﬁbrils have been developed with potential uses as
iomaterials [33—36,144,150,151]. The best characterized
nd most common collagen form is the D-periodic ﬁbril,
bserved as the major structural component in tendon, skin
nd most other connective tissues. Rele et al. developed
collagen-mimetic peptide, NH-(Pro-Arg-Gly)4-(Pro-Hyp-
ly)4-(Glu-Hyp-Gly)4-COOH (CPII), in which the sequence
as designed to exhibit linear ﬁbril growth upon assem-
ly of the triple-helical structure into D-periodic microﬁbrils
152]. (Pro-Hyp-Gly)4 sequence formed a hydrophobic core,
hich facilitated the preferred linear oligomerization within
ﬁbril and staggered orientation between adjacent ﬁbrils.
ven at low concentrations and neutral pH, the oligopep-
ide showed a high propensity for self-association following
nucleation-growth mechanism.
Fields et al. have developed collagen-like peptide
mphiphiles [135,153]. A triple-helical polypeptide of 124
mino acids, where Gly-Pro-Hyp triplets induced triple helic-
b
S
m
c
tucture. Reproduced with permission from Ref. [136].
ty, incorporated residues 1263—1277 of alpha 1 (IV) collagen
o which highly metastatic mouse melanoma cells were
hown to adhere [154].
Bioadhesive surfaces incorporating triple-helical
ollagen-mimetic peptides of the hexapeptide sequence
FOGER from residues 502—507 of the 1(I) chain of type
collagen were engineered to exhibit speciﬁcity for the
ntegrin receptor 21 and focal adhesion formation, with
n ultimate aim to control intracellular signaling and cell
unction [155].
Collagen-mimetic peptides supplemented with the
FOGER sequence and the EDGFFKI and APQQEA substrate
equences were conjugated onto a dendrimer, resulting in a
ross-linkable collagen-mimetic dendrimer [156]. The den-
rimer was used as a template to enhance intramolecular
olding thus stabilizing the triple-helical structures. The
FOGER cell-binding sequence was sandwiched between the
tructural domains, repeating Gly-Pro-Hyp triplets, whereas
he APQQEA or the EDGFFKI sequences were placed at the
xtension of the C-termini of the collagen-mimetic peptides.
onclusions
elf-assembly is an important part of natural materials
esign. Nature can build thousands of nanostructures from
0 amino acids. So, through using the nature as a guide
o understand the interactions and forces in molecular
elf-assembly, it has become possible to mimic the natu-
al processes in order to produce numerous well-deﬁned
anoscale objects. Several self-assembling peptidic nanos-
ructures have been developed, ranging from designs to
tudy protein folding to nanoscale assemblies including nan-
tubes, nanovesicles and nanoﬁbers.
Self-assembly is a bottom-up technology with many
dvantages over top-down approaches, including three-
imensional assembly, versatility, cost-effective large-scale
roduction, and achievement of near-atomic feature size.
elf-assembly into desired structures occurs through molec-
lar recognition, wherein the non-covalent interactions
etween two molecules are both energetic and speciﬁc.
hese interactions consist of hydrogen bonding, electro-
tatic, hydrophobic and aromatic interactions. The level of
nteraction is deﬁned by all these effects balanced against
he tendency toward entropic disorder.
Different molecular entities can be used in the self-
ssembled materials; however, peptides are particularly
ttractive as building blocks because they are chem-
cally versatile, biodegradable, biocompatible, and can
e manipulated to adopt different secondary structures.
elf-assembling nanostructures based on biological macro-
olecules are interesting because of their potential
hemical and structural diversity. Functionalizing nanos-
ructures has been achieved by incorporation of various
Self-assembled peptidic nanostructures
biologically active structures. Thereby, molecular selectiv-
ity, speciﬁcity and activity in self-assembled nanostructures
are promoted. The physical and chemical mechanisms
underlying the assembly of these nanostructures are still
developing and many potential biological applications are
yet to be fully realized. Self-assembling peptides will yield
vast opportunities in developing new functional biomaterials
in near future.
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